Lupin has informed that it enclosed a Press Release as regards, launch of Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg and 90 mg, in the United States, following the recent approval received from the US FDA.
The above information is a part of company’s filings submitted to BSE.